Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Computational Biology | 3 | 2025 | 357 | 1.250 |
Why?
|
| RNA | 2 | 2025 | 429 | 1.100 |
Why?
|
| Biostatistics | 1 | 2025 | 5 | 0.910 |
Why?
|
| Hepatic Stellate Cells | 3 | 2025 | 24 | 0.900 |
Why?
|
| RNA, Long Noncoding | 3 | 2024 | 170 | 0.730 |
Why?
|
| Artificial Intelligence | 1 | 2025 | 197 | 0.720 |
Why?
|
| Software | 1 | 2025 | 388 | 0.710 |
Why?
|
| Biomarkers, Tumor | 1 | 2025 | 512 | 0.700 |
Why?
|
| Gene Expression Regulation | 3 | 2025 | 1621 | 0.520 |
Why?
|
| Adenosine | 1 | 2017 | 78 | 0.510 |
Why?
|
| Genome, Human | 2 | 2020 | 240 | 0.490 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2016 | 36 | 0.480 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 161 | 0.440 |
Why?
|
| Liver Cirrhosis | 3 | 2025 | 180 | 0.430 |
Why?
|
| Phylogeny | 1 | 2014 | 385 | 0.390 |
Why?
|
| Human Embryonic Stem Cells | 2 | 2020 | 38 | 0.290 |
Why?
|
| Transforming Growth Factor beta | 2 | 2021 | 174 | 0.270 |
Why?
|
| Methyltransferases | 2 | 2017 | 63 | 0.240 |
Why?
|
| Liver | 3 | 2025 | 868 | 0.240 |
Why?
|
| Liver Failure, Acute | 1 | 2025 | 26 | 0.230 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2025 | 53 | 0.220 |
Why?
|
| Acetaminophen | 1 | 2025 | 57 | 0.220 |
Why?
|
| Promyelocytic Leukemia Protein | 1 | 2024 | 15 | 0.210 |
Why?
|
| Interleukin-12 | 1 | 2024 | 127 | 0.210 |
Why?
|
| Hematologic Neoplasms | 1 | 2024 | 47 | 0.200 |
Why?
|
| Fatty Liver | 1 | 2024 | 109 | 0.200 |
Why?
|
| Machine Learning | 1 | 2025 | 184 | 0.200 |
Why?
|
| Mice, Knockout | 2 | 2025 | 2140 | 0.190 |
Why?
|
| Signal Transduction | 3 | 2024 | 3070 | 0.190 |
Why?
|
| Interferon-gamma | 1 | 2024 | 576 | 0.180 |
Why?
|
| Palliative Care | 1 | 2024 | 239 | 0.180 |
Why?
|
| Myofibroblasts | 2 | 2025 | 16 | 0.180 |
Why?
|
| Insulin Resistance | 1 | 2024 | 409 | 0.170 |
Why?
|
| Phase Transition | 1 | 2020 | 21 | 0.160 |
Why?
|
| Endoderm | 1 | 2020 | 47 | 0.160 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2021 | 94 | 0.160 |
Why?
|
| Myoblasts | 1 | 2021 | 64 | 0.160 |
Why?
|
| Cell Differentiation | 3 | 2021 | 1365 | 0.160 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 374 | 0.160 |
Why?
|
| Algorithms | 1 | 2025 | 1028 | 0.150 |
Why?
|
| Biomarkers | 1 | 2025 | 1431 | 0.150 |
Why?
|
| MicroRNAs | 1 | 2025 | 697 | 0.140 |
Why?
|
| Macrophages | 1 | 2024 | 1053 | 0.140 |
Why?
|
| Exoribonucleases | 1 | 2017 | 30 | 0.130 |
Why?
|
| Base Sequence | 2 | 2017 | 1332 | 0.130 |
Why?
|
| Half-Life | 1 | 2017 | 79 | 0.130 |
Why?
|
| Methylation | 1 | 2017 | 131 | 0.130 |
Why?
|
| Histones | 1 | 2020 | 486 | 0.130 |
Why?
|
| RNA Stability | 1 | 2017 | 103 | 0.130 |
Why?
|
| Exons | 1 | 2017 | 201 | 0.120 |
Why?
|
| DNA Transposable Elements | 1 | 2017 | 139 | 0.120 |
Why?
|
| Obesity | 1 | 2024 | 1247 | 0.120 |
Why?
|
| HeLa Cells | 1 | 2017 | 540 | 0.120 |
Why?
|
| Transcription Initiation Site | 1 | 2016 | 51 | 0.120 |
Why?
|
| Humans | 9 | 2025 | 64238 | 0.120 |
Why?
|
| Organ Specificity | 1 | 2016 | 196 | 0.120 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2016 | 110 | 0.120 |
Why?
|
| Cluster Analysis | 1 | 2016 | 263 | 0.110 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2016 | 146 | 0.110 |
Why?
|
| Mice | 6 | 2025 | 11003 | 0.110 |
Why?
|
| Collagen Type I | 2 | 2025 | 42 | 0.110 |
Why?
|
| Adenine | 1 | 2014 | 50 | 0.110 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 313 | 0.110 |
Why?
|
| RNA, Ribosomal | 1 | 2014 | 57 | 0.100 |
Why?
|
| RNA-Binding Proteins | 1 | 2017 | 443 | 0.100 |
Why?
|
| Embryonic Stem Cells | 1 | 2014 | 157 | 0.100 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 272 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 416 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2020 | 1540 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 783 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2017 | 1551 | 0.090 |
Why?
|
| Animals | 6 | 2025 | 20961 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 2238 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 2 | 2025 | 3450 | 0.070 |
Why?
|
| Male | 5 | 2025 | 30294 | 0.060 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2025 | 15 | 0.060 |
Why?
|
| Glutathione Transferase | 1 | 2025 | 41 | 0.060 |
Why?
|
| Lipid Droplets | 1 | 2025 | 34 | 0.050 |
Why?
|
| Receptors, Interferon | 1 | 2024 | 21 | 0.050 |
Why?
|
| RNA, Small Interfering | 2 | 2025 | 927 | 0.050 |
Why?
|
| Actins | 1 | 2025 | 261 | 0.050 |
Why?
|
| Diet, High-Fat | 1 | 2024 | 176 | 0.050 |
Why?
|
| Cell Movement | 1 | 2025 | 466 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2024 | 788 | 0.040 |
Why?
|
| Sex Factors | 1 | 2024 | 979 | 0.040 |
Why?
|
| Cell Fusion | 1 | 2021 | 39 | 0.040 |
Why?
|
| Myofibrils | 1 | 2021 | 19 | 0.040 |
Why?
|
| Chickens | 1 | 2021 | 94 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2021 | 215 | 0.040 |
Why?
|
| Acetylation | 1 | 2020 | 123 | 0.040 |
Why?
|
| Cell Communication | 1 | 2021 | 132 | 0.040 |
Why?
|
| Lysine | 1 | 2020 | 87 | 0.040 |
Why?
|
| Medicaid | 1 | 2024 | 362 | 0.040 |
Why?
|
| Age Factors | 1 | 2024 | 1569 | 0.040 |
Why?
|
| Protein Domains | 1 | 2020 | 154 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2025 | 889 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 268 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2021 | 901 | 0.040 |
Why?
|
| Dependovirus | 1 | 2025 | 721 | 0.040 |
Why?
|
| Hospitalization | 1 | 2024 | 1368 | 0.030 |
Why?
|
| Nanog Homeobox Protein | 1 | 2014 | 14 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2014 | 173 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 5520 | 0.030 |
Why?
|
| Young Adult | 1 | 2024 | 4776 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2014 | 103 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2014 | 517 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2014 | 273 | 0.020 |
Why?
|
| Adolescent | 1 | 2024 | 6304 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 1997 | 0.020 |
Why?
|
| Transcriptome | 1 | 2014 | 396 | 0.020 |
Why?
|
| United States | 1 | 2024 | 7923 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 644 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1001 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 2055 | 0.020 |
Why?
|
| Female | 2 | 2024 | 33350 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 14648 | 0.020 |
Why?
|
| Adult | 1 | 2024 | 17116 | 0.020 |
Why?
|
| Middle Aged | 1 | 2024 | 17898 | 0.020 |
Why?
|
| Mutation | 1 | 2014 | 2629 | 0.020 |
Why?
|